CAPN3: A muscle‑specific calpain with an important role in the pathogenesis of diseases (Review)

Sorimachi H, Imajoh-Ohmi S, Emori Y, Kawasaki H, Ohno S, Minami Y and Suzuki K: Molecular cloning of a novel mammalian calcium-dependent protease distinct from both m- and mu-types. Specific expression of the mRNA in skeletal muscle. J Biol Chem. 264:20106–20111. 1989. View Article : Google Scholar

Ono Y, Ojima K, Shinkai-Ouchi F, Hata S and Sorimachi H: An eccentric calpain, CAPN3/p94/calpain-3. Biochimie. 122:169–187. 2016. View Article : Google Scholar

Ohno S, Minoshima S, Kudoh J, Fukuyama R, Shimizu Y, Ohmi-Imajoh S, Shimizu N and Suzuki K: Four genes for the calpain family locate on four distinct human chromosomes. Cytogenet Cell Genet. 53:225–229. 1990. View Article : Google Scholar

Fougerousse F, Durand M, Suel L, Pourquié O, Delezoide AL, Romero NB, Abitbol M and Beckmann JS: Expression of genes (CAPN3, SGCA, SGCB, and TTN) involved in progressive muscular dystrophies during early human development. Genomics. 48:145–156. 1998. View Article : Google Scholar

Fougerousse F, Anderson LV, Delezoide AL, Suel L, Durand M and Beckmann JS: Calpain3 expression during human cardiogenesis. Neuromuscul Disord. 10:251–256. 2000. View Article : Google Scholar

König N, Raynaud F, Feane H, Durand M, Mestre-Francès N, Rossel M, Ouali A and Benyamin Y: Calpain 3 is expressed in astrocytes of rat and Microcebus brain. J Chem Neuroanat. 25:129–136. 2003. View Article : Google Scholar

Marcilhac A, Raynaud F, Clerc I and Benyamin Y: Detection and localization of calpain 3-like protease in a neuronal cell line: Possible regulation of apoptotic cell death through degradation of nuclear IkappaBalpha. Int J Biochem Cell Biol. 38:2128–2140. 2006. View Article : Google Scholar

McCartney CE, Ye Q, Campbell RL and Davies PL: Insertion sequence 1 from calpain-3 is functional in calpain-2 as an internal propeptide. J Biol Chem. 293:17716–17730. 2018. View Article : Google Scholar

Ye Q, Campbell RL and Davies PL: Structures of human calpain-3 protease core with and without bound inhibitor reveal mechanisms of calpain activation. J Biol Chem. 293:4056–4070. 2018. View Article : Google Scholar

Imajoh S, Kawasaki H and Suzuki K: The COOH-terminal E-F hand structure of calcium-activated neutral protease (CANP) is important for the association of subunits and resulting proteolytic activity. J Biochem. 101:447–452. 1987. View Article : Google Scholar

Partha SK, Ravulapalli R, Allingham JS, Campbell RL and Davies PL: Crystal structure of calpain-3 penta-EF-hand (PEF) domain-a homodimerized PEF family member with calcium bound at the fifth EF-hand. FEBS J. 281:3138–3149. 2014. View Article : Google Scholar

Hata S, Doi N, Shinkai-Ouchi F and Ono Y: A muscle-specific calpain, CAPN3, forms a homotrimer. Biochim Biophys Acta Proteins Proteom. 1868:1404112020. View Article : Google Scholar

Ma H, Fukiage C, Azuma M and Shearer TR: Cloning and expression of mRNA for calpain Lp82 from rat lens: Splice variant of p94. Invest Ophthalmol Vis Sci. 39:454–461. 1998.

Ma H, Shih M, Fukiage C, Azuma M, Duncan MK, Reed NA, Richard I, Beckmann JS and Shearer TR: Influence of specific regions in Lp82 calpain on protein stability, activity, and localization within lens. Invest Ophthalmol Vis Sci. 41:4232–4239. 2000.

Ma H, Shih M, Hata I, Fukiage C, Azuma M and Shearer TR: Lp85 calpain is an enzymatically active rodent-specific isozyme of lens Lp82. Curr Eye Res. 20:183–189. 2000. View Article : Google Scholar

Herasse M, Ono Y, Fougerousse F, Kimura E, Stockholm D, Beley C, Montarras D, Pinset C, Sorimachi H, Suzuki K, et al: Expression and functional characteristics of calpain 3 isoforms generated through tissue-specific transcriptional and posttranscriptional events. Mol Cell Biol. 19:4047–4055. 1999. View Article : Google Scholar

Azuma M, Fukiage C, Higashine M, Nakajima T, Ma H and Shearer TR: Identification and characterization of a retina-specific calpain (Rt88) from rat. Curr Eye Res. 21:710–720. 2000. View Article : Google Scholar

Nakajima T, Fukiage C, Azuma M, Ma H and Shearer TR: Different expression patterns for ubiquitous calpains and Capn3 splice variants in monkey ocular tissues. Biochim Biophys Acta. 1519:55–64. 2001. View Article : Google Scholar

Ono Y, Iemura S, Novak SM, Doi N, Kitamura F, Natsume T, Gregorio CC and Sorimachi H: PLEIAD/SIMC1/C5orf25, a novel autolysis regulator for a skeletal-muscle-specific calpain, CAPN3, scaffolds a CAPN3 substrate, CTBP1. J Mol Biol. 425:2955–2972. 2013. View Article : Google Scholar

Ermolova N, Kramerova I and Spencer MJ: Autolytic activation of calpain 3 proteinase is facilitated by calmodulin protein. J Biol Chem. 290:996–1004. 2015. View Article : Google Scholar

Ono Y and Sorimachi H: Calpains: An elaborate proteolytic system. Biochim Biophys Acta. 1824:224–236. 2012. View Article : Google Scholar

Sorimachi H and Kawabata Y: Calpain and pathology in view of structure-function relationships. Nihon Yakurigaku Zasshi. 122:21–29. 2003.In Japanese. View Article : Google Scholar

Sorimachi H, Toyama-Sorimachi N, Saido TC, Kawasaki H, Sugita H, Miyasaka M, Arahata K, Ishiura S and Suzuki K: Muscle-specific calpain, p94, is degraded by autolysis immediately after translation, resulting in disappearance from muscle. J Biol Chem. 268:10593–10605. 1993. View Article : Google Scholar

Rey MA and Davies PL: The protease core of the muscle-specific calpain, p94, undergoes Ca2+-dependent intramolecular autolysis. FEBS Lett. 532:401–406. 2002. View Article : Google Scholar

Diaz BG, Moldoveanu T, Kuiper MJ, Campbell RL and Davies PL: Insertion sequence 1 of muscle-specific calpain, p94, acts as an internal propeptide. J Biol Chem. 279:27656–27666. 2004. View Article : Google Scholar

Fukiage C, Nakajima E, Ma H, Azuma M and Shearer TR: Characterization and regulation of lens-specific calpain Lp82. J Biol Chem. 277:20678–20685. 2002. View Article : Google Scholar

Ono Y, Torii F, Ojima K, Doi N, Yoshioka K, Kawabata Y, Labeit D, Labeit S, Suzuki K, Abe K, et al: Suppressed disassembly of autolyzing p94/CAPN3 by N2A connectin/titin in a genetic reporter system. J Biol Chem. 281:18519–18531. 2006. View Article : Google Scholar

Ono Y, Hayashi C, Doi N, Tagami M and Sorimachi H: The importance of conserved amino acid residues in p94 protease sub-domain IIb and the IS2 region for constitutive autolysis. FEBS Lett. 582:691–698. 2008. View Article : Google Scholar

Hata S, Doi N, Kitamura F and Sorimachi H: Stomach-specific calpain, nCL-2/calpain 8, is active without calpain regulatory subunit and oligomerizes through C2-like domains. J Biol Chem. 282:27847–27856. 2007. View Article : Google Scholar

Parr T, Sensky PL, Scothern GP, Bardsley RG, Buttery PJ, Wood JD and Warkup C: Relationship between skeletal muscle-specific calpain and tenderness of conditioned porcine longissimus muscle. J Anim Sci. 77:661–668. 1999. View Article : Google Scholar

Ono Y, Shindo M, Doi N, Kitamura F, Gregorio CC and Sorimachi H: The N- and C-terminal autolytic fragments of CAPN3/p94/calpain-3 restore proteolytic activity by inter- molecular complementation. Proc Natl Acad Sci USA. 111:E5527–E5536. 2014. View Article : Google Scholar

Sáenz A, Ono Y, Sorimachi H, Goicoechea M, Leturcq F, Blázquez L, García-Bragado F, Marina A, Poza JJ, Azpitarte M, et al: Does the severity of the LGMD2A phenotype in compound heterozygotes depend on the combination of mutations? Muscle Nerve. 44:710–714. 2011. View Article : Google Scholar

Ojima K, Ono Y, Hata S, Koyama S, Doi N and Sorimachi H: Possible functions of p94 in connectin-mediated signaling pathways in skeletal muscle cells. J Muscle Res Cell Motil. 26:409–417. 2005. View Article : Google Scholar

Kramerova I, Torres JA, Eskin A, Nelson SF and Spencer MJ: Calpain 3 and CaMKIIβ signaling are required to induce HSP70 necessary for adaptive muscle growth after atrophy. Hum Mol Genet. 27:1642–1653. 2018. View Article : Google Scholar

Murphy RM, Vissing K, Latchman H, Lamboley C, McKenna MJ, Overgaard K and Lamb GD: Activation of skeletal muscle calpain-3 by eccentric exercise in humans does not result in its translocation to the nucleus or cytosol. J Appl Physiol (1985). 111:1448–1458. 2011. View Article : Google Scholar

Baghdiguian S, Martin M, Richard I, Pons F, Astier C, Bourg N, Hay RT, Chemaly R, Halaby G, Loiselet J, et al: Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the IkappaB alpha/NF-kappaB pathway in limb-girdle muscular dystrophy type 2A. Nat Med. 5:5031999. View Article : Google Scholar

Sorimachi H, Kinbara K, Kimura S, Takahashi M, Ishiura S, Sasagawa N, Sorimachi N, Shimada H, Tagawa K, Maruyama K, et al: Muscle-specific calpain, p94, responsible for limb girdle muscular dystrophy type 2A, associates with connectin through IS2, a p94-specific sequence. J Biol Chem. 270:31158–31162. 1995. View Article : Google Scholar

Taveau M, Bourg N, Sillon G, Roudaut C, Bartoli M and Richard I: Calpain 3 is activated through autolysis within the active site and lyses sarcomeric and sarcolemmal components. Mol Cell Biol. 23:9127–9135. 2003. View Article : Google Scholar

Kramerova I, Kudryashova E, Wu B, Ottenheijm C, Granzier H and Spencer MJ: Novel role of calpain-3 in the triad-associated protein complex regulating calcium release in skeletal muscle. Hum Mol Genet. 17:3271–3280. 2008. View Article : Google Scholar

Kramerova I, Ermolova N, Eskin A, Hevener A, Quehenberger O, Armando AM, Haller R, Romain N, Nelson SF and Spencer MJ: Failure to up-regulate transcription of genes necessary for muscle adaptation underlies limb girdle muscular dystrophy 2A (calpainopathy). Hum Mol Genet. 25:2194–2207. 2016. View Article : Google Scholar

Michel LY, Hoenderop JG and Bindels RJ: Calpain-3-mediated regulation of the Na⁺-Ca²⁺ exchanger isoform 3. Pflugers Arch. 468:243–255. 2016. View Article : Google Scholar

Beckmann JS and Spencer M: Calpain 3, the 'gatekeeper' of proper sarcomere assembly, turnover and maintenance. Neuromuscul Disord. 18:913–921. 2008. View Article : Google Scholar

de Andrade Rosa I, Corrêa S, Costa ML and Mermelstein C: The scaffolding protein calpain-3 has multiple distributions in embryonic chick muscle cells and it is essential for the formation of muscle fibers. Tissue Cell. 67:1014362020. View Article : Google Scholar

Guyon JR, Kudryashova E, Potts A, Dalkilic I, Brosius MA, Thompson TG, Beckmann JS, Kunkel LM and Spencer MJ: Calpain 3 cleaves filamin C and regulates its ability to interact with gamma- and delta-sarcoglycans. Muscle Nerve. 28:472–483. 2003. View Article : Google Scholar

Kramerova I, Kudryashova E, Wu B and Spencer MJ: Regulation of the M-cadherin-beta-catenin complex by calpain 3 during terminal stages of myogenic differentiation. Mol Cell Biol. 26:8437–8447. 2006. View Article : Google Scholar

Stuelsatz P, Pouzoulet F, Lamarre Y, Dargelos E, Poussard S, Leibovitch S, Cottin P and Veschambre P: Down-regulation of MyoD by calpain 3 promotes generation of reserve cells in C2C12 myoblasts. J Biol Chem. 285:12670–12683. 2010. View Article : Google Scholar

Stockholm D, Herasse M, Marchand S, Praud C, Roudaut C, Richard I, Sebille A and Beckmann JS: Calpain 3 mRNA expression in mice after denervation and during muscle regeneration. Am J Physiol Cell Physiol. 280:C1561–C1569. 2001. View Article : Google Scholar

Wu R, Yan Y, Yao J, Liu Y, Zhao J and Liu M: Calpain 3 expression pattern during gastrocnemius muscle atrophy and regeneration following sciatic nerve injury in rats. Int J Mol Sci. 16:26927–26935. 2015. View Article : Google Scholar

Cohen N, Kudryashova E, Kramerova I, Anderson LV, Beckmann JS, Bushby K and Spencer MJ: Identification of putative in vivo substrates of calpain 3 by comparative proteomics of overexpressing transgenic and nontransgenic mice. Proteomics. 6:6075–6084. 2006. View Article : Google Scholar

de Morrée A, Lutje Hulsik D, Impagliazzo A, van Haagen HH, de Galan P, van Remoortere A, 't Hoen PA, van Ommen GB, Frants RR and van der Maarel SM: Calpain 3 is a rapid-action, unidirectional proteolytic switch central to muscle remodeling. PLoS One. 5:e119402010. View Article : Google Scholar

Kramerova I, Kudryashova E, Venkatraman G and Spencer MJ: Calpain 3 participates in sarcomere remodeling by acting upstream of the ubiquitin-proteasome pathway. Hum Mol Genet. 14:2125–2134. 2005. View Article : Google Scholar

Hauerslev S, Sveen ML, Duno M, Angelini C, Vissing J and Krag TO: Calpain 3 is important for muscle regeneration: Evidence from patients with limb girdle muscular dystrophies. BMC Musculoskelet Disord. 13:432012. View Article : Google Scholar

Richard I, Roudaut C, Marchand S, Baghdiguian S, Herasse M, Stockholm D, Ono Y, Suel L, Bourg N, Sorimachi H, et al: Loss of calpain 3 proteolytic activity leads to muscular dystrophy and to apoptosis-associated IkappaBalpha/nuclear factor kappaB pathway perturbation in mice. J Cell Biol. 151:1583–1590. 2000. View Article : Google Scholar

DeArmond S, Fajardo M, Naughton S and Eng L: Degradation of glial fibrillary acidic protein by a calcium dependent proteinase: An electroblot study. Brain Res. 262:275–282. 1983. View Article : Google Scholar

Lepekhin EA, Eliasson C, Berthold CH, Berezin V, Bock E and Pekny M: Intermediate filaments regulate astrocyte motility. J Neurochem. 79:617–625. 2001. View Article : Google Scholar

Alvarez-Buylla A, Seri B and Doetsch F: Identification of neural stem cells in the adult vertebrate brain. Brain Res Bull. 57:751–758. 2002. View Article : Google Scholar

Schmidt WM, Uddin MH, Dysek S, Moser-Their K, Pirker C, Höger H, Ambros IM, Ambros PF, Berger W and Bittner RE: DNA damage, somatic aneuploidy, and malignant sarcoma susceptibility in muscular dystrophies. PLoS Genet. 7:e10020422011. View Article : Google Scholar

Oliveira Santos M, Ninitas P and Conceição I: Severe limb-girdle muscular dystrophy 2A in two young siblings from Guinea-Bissau associated with a novel null homozygous mutation in CAPN3 gene. Neuromuscul Disord. 28:1003–1005. 2018. View Article : Google Scholar

Ono Y, Sorimachi H and Suzuki K: New aspect of the research on limb-girdle muscular dystrophy 2A: A molecular biologic and biochemical approach to pathology. Trends Cardiovasc Med. 9:114–118. 1999. View Article : Google Scholar

Richard I, Roudaut C, Saenz A, Pogue R, Grimbergen JE, Anderson LV, Beley C, Cobo AM, de Diego C, Eymard B, et al: Calpainopathy-a survey of mutations and polymorphisms. Am J Hum Genet. 64:1524–1540. 1999. View Article : Google Scholar

Chae J, Minami N, Jin Y, Nakagawa M, Murayama K, Igarashi F and Nonaka I: Calpain 3 gene mutations: Genetic and clinico-pathologic findings in limb-girdle muscular dystrophy. Neuromuscul Disord. 11:547–555. 2001. View Article : Google Scholar

Fanin M, Nascimbeni AC, Fulizio L, Trevisan CP, Meznaric-Petrusa M and Angelini C: Loss of calpain-3 auto- catalytic activity in LGMD2A patients with normal protein expression. Am J Pathol. 163:1929–1936. 2003. View Article : Google Scholar

Peddareddygari LR, Surgan V and Grewal RP: Limb-girdle muscular dystrophy type 2A resulting from homozygous G2338C transversion mutation in the calpain-3 gene. J Clin Neuromuscul Dis. 12:62–65. 2010. View Article : Google Scholar

Perez F, Vital A, Martin-Negrier ML, Ferrer X and Sole G: Diagnostic procedure of limb girdle muscular dystrophies 2A or calpainopathies: French cohort from a neuromuscular center (Bordeaux). Rev Neurol (Paris). 166:502–508. 2010.In French. View Article : Google Scholar

Fanin M, Fulizio L, Nascimbeni AC, Spinazzi M, Piluso G, Ventriglia VM, Ruzza G, Siciliano G, Trevisan CP, Politano L, et al: Molecular diagnosis in LGMD2A: Mutation analysis or protein testing? Hum Mutat. 24:52–62. 2004. View Article : Google Scholar

Fanin M, Nascimbeni AC and Angelini C: Screening of calpain-3 autolytic activity in LGMD muscle: A functional map of CAPN3 gene mutations. J Med Genet. 44:38–43. 2007. View Article : Google Scholar

Pathak P, Sharma MC, Sarkar C, Jha P, Suri V, Mohd H, Singh S, Bhatia R and Gulati S: Limb girdle muscular dystrophy type 2A in India: A study based on semi-quantitative protein analysis, with clinical and histopathological correlation. Neurol India. 58:549–554. 2010. View Article : Google Scholar

Chrobáková T, Hermanová M, Kroupová I, Vondrácek P, Maríková T, Mazanec R, Zámecník J, Stanek J, Havlová M and Fajkusová L: Mutations in Czech LGMD2A patients revealed by analysis of calpain3 mRNA and their phenotypic outcome. Neuromuscul Disord. 14:659–665. 2004. View Article : Google Scholar

Ermolova N, Kudryashova E, DiFranco M, Vergara J, Kramerova I and Spencer MJ: Pathogenity of some limb girdle muscular dystrophy mutations can result from reduced anchorage to myofibrils and altered stability of calpain 3. Hum Mol Genet. 20:3331–3345. 2011. View Article : Google Scholar

Duguez S, Bartoli M and Richard I: Calpain 3: A key regulator of the sarcomere? FEBS J. 273:3427–3436. 2006. View Article : Google Scholar

Groen EJ, Charlton R, Barresi R, Anderson LV, Eagle M, Hudson J, Koref MS, Straub V and Bushby KM: Analysis of the UK diagnostic strategy for limb girdle muscular dystrophy 2A. Brain. 130:3237–3249. 2007. View Article : Google Scholar

Chiannilkulchai N, Pasturaud P, Richard I, Auffray C and Beckmann JS: A primary expression map of the chromosome 15q15 region containing the recessive form of limb-girdle muscular dystrophy (LGMD2A) gene. Hum Mol Genet. 4:717–725. 1995. View Article : Google Scholar

Ojima K, Kawabata Y, Nakao H, Nakao K, Doi N, Kitamura F, Ono Y, Hata S, Suzuki H, Kawahara H, et al: Dynamic distribution of muscle-specific calpain in mice has a key role in physical-stress adaptation and is impaired in muscular dystrophy. J Clin Invest. 120:2672–2683. 2010. View Article : Google Scholar

Baghdiguian S, Richard I, Martin M, Coopman P, Beckmann JS, Mangeat P and Lefranc G: Pathophysiology of limb girdle muscular dystrophy type 2A: Hypothesis and new insights into the IkappaBalpha/NF-kappaB survival pathway in skeletal muscle. J Mol Med (Berl). 79:254–261. 2001. View Article : Google Scholar

Benayoun B, Baghdiguian S, Lajmanovich A, Bartoli M, Daniele N, Gicquel E, Bourg N, Raynaud F, Pasquier MA, Suel L, et al: NF-kappaB-dependent expression of the anti- apoptotic factor c-FLIP is regulated by calpain 3, the protein involved in limb-girdle muscular dystrophy type 2A. FASEB J. 22:1521–1529. 2008. View Article : Google Scholar

Nilsson MI, Macneil LG, Kitaoka Y, Alqarni F, Suri R, Akhtar M, Haikalis ME, Dhaliwal P, Saeed M and Tarnopolsky MA: Redox state and mitochondrial respiratory chain function in skeletal muscle of LGMD2A patients. PLoS One. 9:e1025492014. View Article : Google Scholar

Yalvac ME, Amornvit J, Braganza C, Chen L, Hussain SA, Shontz KM, Montgomery CL, Flanigan KM, Lewis S and Sahenk Z: Impaired regeneration in calpain-3 null muscle is associated with perturbations in mTORC1 signaling and defective mitochondrial biogenesis. Skelet Muscle. 7:272017. View Article : Google Scholar

Gallardo E, Saenz A and Illa I: Limb-girdle muscular dystrophy 2A. Handb Clin Neurol. 101:97–110. 2011. View Article : Google Scholar

Toral-Ojeda I, Aldanondo G, Lasa-Elga r resta J, Lasa-Fernández H, Fernández-Torrón R, López de Munain A and Vallejo-Illarramendi A: Calpain 3 deficiency affects SERCA expression and function in the skeletal muscle. Expert Rev Mol Med. 18:e72016. View Article : Google Scholar

Lasa-Elgarresta J, Mosqueira-Martín L, Naldaiz-Gastesi N, Sáenz A, López de Munain A and Vallejo-Illarramendi A: Calcium mechanisms in limb-girdle muscular dystrophy with CAPN3 mutations. Int J Mol Sci. 20:45482019. View Article : Google Scholar

DiFranco M, Kramerova I, Vergara JL and Spencer MJ: Attenuated Ca(2+) release in a mouse model of limb girdle muscular dystrophy 2A. Skelet Muscle. 6:112016. View Article : Google Scholar

Kramerova I, Kudryashova E, Ermolova N, Saenz A, Jaka O, López de Munain A and Spencer MJ: Impaired calcium calmodulin kinase signaling and muscle adaptation response in the absence of calpain 3. Hum Mol Genet. 21:3193–3204. 2012. View Article : Google Scholar

Liu J, Campagna J, John V, Damoiseaux R, Mokhonova E, Becerra D, Meng H, McNally EM, Pyle AD, Kramerova I and Spencer MJ: A small-molecule approach to restore A slow-oxidative phenotype and defective CaMKIIβ signaling in limb girdle muscular dystrophy. Cell Rep Med. 1:1001222020. View Article : Google Scholar

Laure L, Danièle N, Suel L, Marchand S, Aubert S, Bourg N, Roudaut C, Duguez S, Bartoli M and Richard I: A new pathway encompassing calpain 3 and its newly identified substrate cardiac ankyrin repeat protein is involved in the regulation of the nuclear factor-κB pathway in skeletal muscle. FEBS J. 277:4322–4337. 2010. View Article : Google Scholar

Fanin M, Pegoraro E, Matsuda-Asada C, Brown RH Jr and Angelini C: Calpain-3 and dysferlin protein screening in patients with limb-girdle dystrophy and myopathy. Neurology. 56:660–665. 2001. View Article : Google Scholar

Huang Y, de Morrée A, van Remoortere A, Bushby K, Frants RR, den Dunnen JT and van der Maarel SM: Calpain 3 is a modulator of the dysferlin protein complex in skeletal muscle. Hum Mol Genet. 17:1855–1866. 2008. View Article : Google Scholar

Anderson LV, Harrison RM, Pogue R, Vafiadaki E, Pollitt C, Davison K, Moss JA, Keers S, Pyle A, Shaw PJ, et al: Secondary reduction in calpain 3 expression in patients with limb girdle muscular dystrophy type 2B and Miyoshi myopathy (primary dysferlinopathies). Neuromuscul Disord. 10:553–559. 2000. View Article : Google Scholar

Haravuori H, Vihola A, Straub V, Auranen M, Richard I, Marchand S, Voit T, Labeit S, Somer H, Peltonen L, et al: Secondary calpain3 deficiency in 2q-linked muscular dystrophy: Titin is the candidate gene. Neurology. 56:869–877. 2001. View Article : Google Scholar

Charton K, Sarparanta J, Vihola A, Milic A, Jonson PH, Suel L, Luque H, Boumela I, Richard I and Udd B: CAPN3-mediated processing of C-terminal titin replaced by pathological cleavage in titinopathy. Hum Mol Genet. 24:3718–3731. 2015. View Article : Google Scholar

Charton K, Danièle N, Vihola A, Roudaut C, Gicquel E, Monjaret F, Tarrade A, Sarparanta J, Udd B and Richard I: Removal of the calpain 3 protease reverses the myopathology in a mouse model for titinopathies. Hum Mol Genet. 19:4608–4624. 2010. View Article : Google Scholar

Persiconi I, Cosmi F, Guadagno NA, Lupo G and De Stefano ME: Dystrophin is required for the proper timing in retinal histogenesis: A thorough investigation on the mdx mouse model of duchenne muscular dystrophy. Front Neurosci. 14:7602020. View Article : Google Scholar

Pastorello E, Cao M and Trevisan CP: Atypical onset in a series of 122 cases with facioscapulohumeral muscular dystrophy. Clin Neurol Neurosurg. 114:230–234. 2012. View Article : Google Scholar

Sacconi S, Camaño P, de Greef JC, Lemmers RJ, Salviati L, Boileau P, Lopez de Munain Arregui A, van der Maarel SM and Desnuelle C: Patients with a phenotype consistent with facioscapulohumeral muscular dystrophy display genetic and epigenetic heterogeneity. J Med Genet. 49:41–46. 2012. View Article : Google Scholar

Pistoni M, Shiue L, Cline MS, Bortolanza S, Neguembor MV, Xynos A, Ares M Jr and Gabellini D: Rbfox1 downregulation and altered calpain 3 splicing by FRG1 in a mouse model of Facioscapulohumeral muscular dystrophy (FSHD). PLoS Genet. 9:e10031862013. View Article : Google Scholar

Paco S, Ferrer I, Jou C, Cusí V, Corbera J, Torner F, Gualandi F, Sabatelli P, Orozco A, Gómez-Foix AM, et al: Muscle fiber atrophy and regeneration coexist in collagen VI-deficient human muscle: Role of calpain-3 and nuclear factor-κB signaling. J Neuropathol Exp Neurol. 71:894–906. 2012. View Article : Google Scholar

Krahn M, Lopez de Munain A, Streichenberger N, Bernard R, Pécheux C, Testard H, Pena-Segura JL, Yoldi E, Cabello A, Romero NB, et al: CAPN3 mutations in patients with idiopathic eosinophilic myositis. Ann Neurol. 59:905–911. 2006. View Article : Google Scholar

Parker KC, Kong SW, Walsh RJ, Bch Salajegheh M, Moghadaszadeh B, Amato AA, Nazareno R, Lin YY, Krastins B, et al Fast-twitch sarcomeric and glycolytic enzyme protein loss in inclusion body myositis. Muscle Nerve. 39:739–753. 2009. View Article : Google Scholar

Amici DR, Pinal-Fernandez I, Mázala DA, Lloyd TE, Corse AM, Christopher-Stine L, Mammen AL and Chin ER: Calcium dysregulation, functional calpainopathy, and endoplasmic reticulum stress in sporadic inclusion body myositis. Acta Neuropathol Commun. 5:242017. View Article : Google Scholar

Musumeci O, Aguennouz M, Cagliani R, Comi GP, Ciranni A, Rodolico C, Messina C, Vita G and Toscano A: Calpain 3 deficiency in Quail Eater's disease. Ann Neurol. 55:146–147. 2004. View Article : Google Scholar

Kruijt N, van den Bersselaar LR, Kamsteeg EJ, Verbeeck W, Snoeck MMJ, Everaerd DS, Abdo WF, Jansen DRM, Erasmus CE, Jungbluth H and Voermans NC: The etiology of rhabdomyolysis: An interaction between genetic susceptibility and external triggers. Eur J Neurol. 28:647–659. 2021. View Article : Google Scholar

Weeraratna AT, Becker D, Carr KM, Duray PH, Rosenblatt KP, Yang S, Chen Y, Bittner M, Strausberg RL, Riggins GJ, et al: Generation and analysis of melanoma SAGE libraries: SAGE advice on the melanoma transcriptome. Oncogene. 23:2264–2274. 2004. View Article : Google Scholar

Huynh KM, Kim G, Kim DJ, Yang SJ, Park SM, Yeom YI, Fisher PB and Kang D: Gene expression analysis of terminal differentiation of human melanoma cells highlights global reductions in cell cycle-associated genes. Gene. 433:32–39. 2009. View Article : Google Scholar

Moretti D, Del Bello B, Cosci E, Biagioli M, Miracco C and Maellaro E: Novel variants of muscle calpain 3 identified in human melanoma cells: Cisplatin-induced changes in vitro and differential expression in melanocytic lesions. Carcinogenesis. 30:960–967. 2009. View Article : Google Scholar

Moretti D, Del Bello B, Allavena G, Corti A, Signorini C and Maellaro E: Calpain-3 impairs cell proliferation and stimulates oxidative stress-mediated cell death in melanoma cells. PLoS One. 10:e01172582015. View Article : Google Scholar

Rambow F, Job B, Petit V, Gesbert F, Delmas V, Seberg H, Meurice G, Van Otterloo E, Dessen P, Robert C, et al: New functional signatures for understanding melanoma biology from tumor cell lineage-specific analysis. Cell Rep. 13:840–853. 2015. View Article : Google Scholar

Ruffini F, Tentori L, Dorio AS, Arcelli D, D'Amati G, D'Atri S, Graziani G and Lacal PM: Platelet-derived growth factor C and calpain-3 are modulators of human melanoma cell invasiveness. Oncol Rep. 30:2887–2896. 2013. View Article : Google Scholar

Pizzanelli C, Mancuso M, Galli R, Choub A, Fanin M, Nascimbeni AC, Siciliano G and Murri L: Epilepsy and limb girdle muscular dystrophy type 2A: Double trouble, serendipitous finding or new phenotype? Neurol Sci. 27:134–136. 2006. View Article : Google Scholar

Viloria-Alebesque A, Bellosta-Diago E, Santos-Lasaosa S and Mauri-Llerda JÁ: Familial association of genetic generalised epilepsy with limb-girdle muscular dystrophy through a mutation in CAPN3. Epilepsy Behav Case Rep. 11:122–124. 2019. View Article : Google Scholar

Sanchez-Mut JV, Aso E, Panayotis N, Lott I, Dierssen M, Rabano A, Urdinguio RG, Fernandez AF, Astudillo A, Martin-Subero JI, et al: DNA methylation map of mouse and human brain identifies target genes in Alzheimer's disease. Brain. 136:3018–3027. 2013. View Article : Google Scholar

De Jager P, Srivastava G, Lunnon K, Burgess J, Schalkwyk LC, Yu L, Eaton ML, Keenan BT, Ernst J, McCabe C, et al: Alzheimer's disease: Early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci. Nat Neurosci. 17:1156–1163. 2014. View Article : Google Scholar

Ma D, Fetahu IS, Wang M, Fang R, Li J, Liu H, Gramyk T, Iwanicki I, Gu S, Xu W, et al: The fusiform gyrus exhibits an epigenetic signature for Alzheimer's disease. Clin Epigenetics. 12:1292020. View Article : Google Scholar

Walder K, McMillan J, Lapsys N, Kriketos A, Trevaskis J, Civitarese A, Southon A, Zimmet P and Collier G: Calpain 3 gene expression in skeletal muscle is associated with body fat content and measures of insulin resistance. Int J Obes Relat Metab Disord. 26:442–449. 2002. View Article : Google Scholar

Norton L, Parr T, Bardsley RG, Ye H and Tsintzas K: Characterization of GLUT4 and calpain expression in healthy human skeletal muscle during fasting and refeeding. Acta Physiol (Oxf). 189:233–240. 2007. View Article : Google Scholar

Varga TV, Kurbasic A, Aine M, Eriksson P, Ali A, Hindy G, Gustafsson S, Luan J, Shungin D, Chen Y, et al: Novel genetic loci associated with long-term deterioration in blood lipid concentrations and coronary artery disease in European adults. Int J Epidemiol. 46:1211–1222. 2017.

Guo T, Yin RX, Pan L, Yang S, Miao L and Huang F: Integrative variants, haplotypes and diplotypes of the CAPN3 and FRMD5 genes and several environmental exposures associate with serum lipid variables. Sci Rep. 7:451192017. View Article : Google Scholar

Salinas-Santander M, Trevino V, De la Rosa-Moreno E, Verduzco-Garza B, Sánchez-Domínguez CN, Cantú-Salinas C, Ocampo-Garza J, Lagos-Rodríguez A, Ocampo-Candiani J and Ortiz-López R: CAPN3, DCT, MLANA and TYRP1 are overexpressed in skin of vitiligo vulgaris Mexican patients. Exp Ther Med. 15:2804–2811. 2018.

Tang Y, Liu X, Zoltoski RK, Novak LA, Herrera RA, Richard I, Kuszak JR and Kumar NM: Age-related cataracts in alpha3Cx46-knockout mice are dependent on a calpain 3 isoform. Invest Ophthalmol Vis Sci. 48:2685–2694. 2007. View Article : Google Scholar

Bartoli M, Roudaut C, Martin S, Fougerousse F, Suel L, Poupiot J, Gicquel E, Noulet F, Danos O and Richard I: Safety and efficacy of AAV-mediated calpain 3 gene transfer in a mouse model of limb-girdle muscular dystrophy type 2A. Mol Ther. 13:250–259. 2006. View Article : Google Scholar

Selvaraj S, Dhoke NR, Kiley J, Mateos-Aierdi AJ, Tungtur S, Mondragon-Gonzalez R, Killeen G, Oliveira VKP, López de Munain A and Perlingeiro RCR: Gene correction of LGMD2A patient-specific iPSCs for the development of targeted autologous cell therapy. Mol Ther. 27:2147–2157. 2019. View Article : Google Scholar